Andersen K, Tjønnfjord GE, Hestdalen ML, Spetalen S, Panagopoulos I (2025)
Complex Genetic Evolution and Treatment Challenges in Myeloid Neoplasms: A Case of Persistent t(2;3)(p15~23;q26)/MECOM Rearrangement, SF3B1 Mutation, and Transient TNIP1::PDGFRB Chimera
Cancer Genomics Proteomics, 22 (1), 24-33
DOI 10.21873/cgp.20483, PubMed 39730178

Wu J, Santos-Garcia I, Eiriz I, Brüning T, Kvasnička A, Friedecký D, Nyman TA, Pahnke J (2024)
Sex-Dependent Efficacy of Sphingosine-1-Phosphate Receptor Agonist FTY720 in Mitigating Huntington's Disease
Pharmacol Res, 107557 (in press)
DOI 10.1016/j.phrs.2024.107557, PubMed 39725338

Bischof K, Holth A, Bassarova A, Davidson B (2024)
Expression of PRAME in high-grade serous carcinoma is associated with higher residual disease volume and Occludin expression
Pathol Res Pract, 266, 155787 (in press)
DOI 10.1016/j.prp.2024.155787, PubMed 39709875